Prevalence and factors of polypharmacy among disease-free survivors of adults after allogeneic hematopoietic cell transplantation

被引：0
|
作者：
Miyashita, Eita [1 ]
Sugihara, Nozomi [1 ]
Tanaka, Miho [1 ]
Iwasaki, Hiromi [1 ]
Monna-Oiwa, Maki [2 ]
Isobe, Masamichi [2 ]
Kato, Seiko [2 ]
Takahashi, Satoshi [2 ]
Nannya, Yasuhito [2 ]
Tsuru, Yukari [1 ]
Konuma, Takaaki [2 ,3 ]
机构：
[1] Univ Tokyo, Res Hosp, Inst Med Sci, Dept Nursing, Tokyo, Japan
[2] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan
[3] Univ Tokyo, Inst Med Sci, Dept hematol oncol, 4-6-1 Shirokanedai Minato ku, Tokyo 1088639, Japan
来源：
LEUKEMIA & LYMPHOMA | 2024年 / 65卷 / 04期
关键词：
D O I：
10.1080/10428194.2023.2298698
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：516 / 520
页数：5
相关论文
共 50 条
  • [1] Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia
    Tan, Jie
    Wang, Ya
    Yu, Si-Jian
    Ma, Yong-Yong
    Lei, Hu-Yi
    Liu, Qi-Fa
    LEUKEMIA RESEARCH, 2017, 59 : 1 - 7
  • [2] Prognostic Factors for Mortality among Day+100 Survivors after Allogeneic Hematopoietic Cell Transplantation
    Patel, Sagar S.
    Rybicki, Lisa A.
    Corrigan, Donna
    Bolwell, Brian
    Dean, Robert
    Liu, Hien
    Gerds, Aaron T.
    Hanna, Rabi
    Hill, Brian
    Jagadeesh, Deepa
    Kalaycio, Matt
    Pohlman, Brad
    Sobecks, Ronald
    Majhail, Navneet S.
    Hamilton, Betty K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (05) : 1029 - 1034
  • [3] Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation
    Goldberg, Jenna D.
    Zheng, Junting
    Barker, Juliet
    Boulad, Farid
    Castro-Malaspina, H. R.
    Hsu, Katharine C.
    Jakubowski, Ann
    Kernan, Nancy
    O'Reilly, Richard J.
    Papadopoulos, Esperanza
    Prockop, Susan
    Scaradavou, Andromachi
    van den Brink, Marcel
    Young, James
    Heller, Glenn
    Perales, Miguel-Angel
    BLOOD, 2009, 114 (22) : 875 - 876
  • [4] Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation
    Liu, Yao-Chung
    Chien, Sheng-Hsuan
    Fan, Nai-Wen
    Hu, Ming-Hung
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Chiou, Tzeon-Jye
    Tzeng, Cheng-Hwai
    Chen, Po-Min
    Liu, Jin-Hwang
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [5] Prognostic Factors for Late Mortality Among Day 100 Survivors after Allogeneic Hematopoietic Cell Transplantation (HCT)
    Patel, Sagar S.
    Rybicki, Lisa
    Abounader, Donna
    Bolwell, Brian J.
    Dean, Robert
    Liu, Hien K.
    Gerds, Aaron T.
    Hanna, Rabi
    Hill, Brian T.
    Jagadeesh, Deepa
    Kalaycio, Matt
    Pohlman, Brad
    Sobecks, Ronald
    Majhail, Navneet S.
    Hamilton, Betty K.
    BLOOD, 2016, 128 (22)
  • [6] Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults
    Sugidono, Matthew
    Lo, Mimi
    Young, Rebecca
    Rosario, Kimberly
    Jung, Yoonie
    Huang, Chiung-Yu
    Sheng, Ying
    Huang, Li-Wen
    Olin, Rebecca L.
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (04): : 344.e1 - 344.e5
  • [7] DISEASE-FREE SURVIVAL OF MYELODYSPLASTIC SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS NOT ASSOCIATED WITH DISEASE STATUS AND DONOR SOURCES
    Lu, Y.
    Wu, T.
    Cao, Y. Xing
    Zhao, L. Yan
    Liu, Y. De
    Zhou, R. Jia
    Zhang, P. Jian
    Xiong, M.
    Lu, D.
    Sun, J. Rui
    Wei, J. Zhi
    Ji, Q. Shen
    BONE MARROW TRANSPLANTATION, 2014, 49 : S185 - S185
  • [8] Disease-Free Survival Of Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Is Not Associated With Disease Status and Donor Sources
    Lu, Yue
    Wu, Tong
    Cao, Xing-Yu
    Zhao, Yan-Li
    Liu, De-Yan
    Zhou, Jia-Rui
    Xiong, Min
    Zhang, Jian-Ping
    Sun, Rui-Juan
    Wei, Zhi-Jie
    Ji, Shu-Quan
    Lu, Dao-Pei
    BLOOD, 2013, 122 (21)
  • [9] HIGH PREVALENCE OF IRON OVERLOAD IN ADULT SURVIVORS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Majbail, N. S.
    DeFor, T. E.
    Kang, B.
    Paley, C.
    Lazarus, H.
    Burns, L. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 54 - 54
  • [10] Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation
    Patel, Ameet
    Wilkerson, Karina
    Chen, Heidi
    Sharma, Deva
    Byrne, Michael
    Green, Jennifer
    Sengsayadeth, Salyka
    Dholaria, Bhagirathbhai
    Savani, Bipin
    Chinratanalab, Wichai
    Jayani, Reena
    Gatwood, Katie
    Engelhardt, Brian G.
    Kitko, Carrie
    Connelly, James
    Kassim, Adetola
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05): : 277.e1 - 277.e6
12345